Christian Hartmann

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 159 publications

Molecularly diagnosed glioblastoma: clinical presentation and outcomes.

Molecularly diagnosed glioblastoma: clinical presentation and outcomes.

Journal: Journal of neuro-oncology

Published: July 02, 2026

Endoscopic third ventriculostomy for obstructive hydrocephalus combined with biopsy for tumors located in the tectum/posterior third ventricle using a single burr hole technique guided by electromagnetic navigation in pediatric neurosurgery.

Endoscopic third ventriculostomy for obstructive hydrocephalus combined with biopsy for tumors located in the tectum/posterior third ventricle using a single burr hole technique guided by electromagnetic navigation in pediatric neurosurgery.

Journal: Clinical neurology and neurosurgery

Published: June 10, 2026

From Recommendation to Implementation: Clinical Outcomes of a Single-Center Molecular Tumor Board.

From Recommendation to Implementation: Clinical Outcomes of a Single-Center Molecular Tumor Board.

Journal: Targeted oncology

Published: February 28, 2026

Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab-soravtansine therapy.

Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab-soravtansine therapy.

Journal: The journal of pathology. Clinical research

Published: January 15, 2026

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Journal: Nature communications

Published: January 09, 2026

Primary mismatch repair deficient glioma, IDH-wildtype and H3-wildtype: A giant cell tumor with potential for long-term survival occurring at all ages.

Primary mismatch repair deficient glioma, IDH-wildtype and H3-wildtype: A giant cell tumor with potential for long-term survival occurring at all ages.

Journal: Neuro-oncology

Published: December 15, 2025

Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all Ages.

Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all Ages.

Journal: Neuro-oncology

Published: December 15, 2025

The Simplified Edinburgh Criteria in Clinical Practice: A CT-Neuropathology Accuracy Study for Diagnosis of Cerebral Amyloid Angiopathy.

The Simplified Edinburgh Criteria in Clinical Practice: A CT-Neuropathology Accuracy Study for Diagnosis of Cerebral Amyloid Angiopathy.

Journal: Neurology

Published: November 06, 2025

Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumors.

Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumors.

Journal: Acta neuropathologica

Published: August 26, 2025

Identification of the adhesion GPCR ADGRL4/ELTD1 as a novel potential prognostic biomarker for cerebral cavernous malformation disease.

Identification of the adhesion GPCR ADGRL4/ELTD1 as a novel potential prognostic biomarker for cerebral cavernous malformation disease.

Journal: Molecular medicine (Cambridge, Mass.)

Published: August 05, 2025

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.

Journal: Neuro-oncology

Published: June 24, 2025

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.

Journal: Neuro-oncology

Published: June 24, 2025

Showing 1-12 of 159

Last Updated: 09/26/2026